| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Oct 07, 2024 | Sale | $0.56 | 76,920 | 43,306 | 388,026 | Oct 08, 2024, 04:44 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Mar 11, 2024 | Sale | $0.88 | 14,235 | 12,552 | 234,301 | Mar 11, 2024, 05:20 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Feb 12, 2024 | Sale | $1.01 | 787 | 793 | 248,536 | Feb 12, 2024, 05:23 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Nov 01, 2023 | Sale | $0.73 | 67,695 | 49,417 | 249,323 | Nov 03, 2023, 04:39 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Mar 10, 2023 | Sale | $0.84 | 16,806 | 14,117 | 86,373 | Mar 13, 2023, 04:48 PM | |
| XFOR | X4 Pharmaceuticals, Inc | Arthur Taveras | Chief Scientific Officer | Feb 13, 2023 | Sale | $0.93 | 928 | 863 | 103,179 | Feb 15, 2023, 05:13 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More